Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Thoracic 2 Head & Neck 2 Dermatologic 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Gastrointestinal Stromal Tumors 3 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Temozolomide 51 Bevacizumab 23 Radiotherapy 16 Magnetic Resonance Spectroscopy 16 Irinotecan 15 Carmustine 12 Erlotinib Hydrochloride 10 Carboplatin 8 Surgical Procedures, Operative 6 O(6)-benzylguanine 6 Imatinib Mesylate 6 Filgrastim 6 Cyclophosphamide 6 Biopsy 6 sargramostim 5 aldesleukin 5 X-Rays 5 Thalidomide 5 Phantoms, Imaging 5 Chemotherapy, Adjuvant 5 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5 temsirolimus 4 Topotecan 4 Specimen Handling 4 Sirolimus 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Nuclear Medicine Department, Hospital 4 Etoposide 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × binimetinib × Sarcoma × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡